genetically modified allogeneic mesenchymal stem cells (Apceth)

N/A

Report date: 2025/03/20 16:01:12

Base Information

Drug Namegenetically modified allogeneic mesenchymal stem cells (Apceth)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionImmunosuppressants
TargetsUpdating
Therapy Area/IndicationsDiabetes Mellitus, Type 1
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmark
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesApceth Gmbh & Co Kg
China Registration ClassN/A

Develop Information

Active CompaniesApceth Gmbh & Co Kg
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 1
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A